Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19494215 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
Condition: Tuberculosis
Interventions: Drug: TMC207;   Drug: Placebo;   Drug: Background regimen (BR) for MDR-TB (multi-drug resistant tuberculosis)
2 Completed Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers
Conditions: Tuberculosis;   HIV
Interventions: Drug: Efavirenz (EFV);   Drug: TMC207

Indicates status has not been verified in more than two years